Regenerative Medicine

On this page

Regenerative Medicine - Healing's New Dawn

Interdisciplinary field aiming to restore normal function of damaged tissues/organs through repair, replacement, or regeneration.

  • Core Pillars:
    • Cell-Based Therapies: Utilizes stem cells (Embryonic ESCs, Induced Pluripotent iPSCs, Mesenchymal MSCs) and somatic cells.
    • Tissue Engineering: Combines biomaterials, scaffolds, cells, and growth factors to create functional tissues.
    • Bioactive Molecules: Employs growth factors and cytokines to stimulate the body's intrinsic repair mechanisms.
  • Key Applications: Organogenesis, diabetes mellitus, heart failure, neurodegenerative diseases (e.g., Parkinson's), spinal cord injuries, severe burns.
  • Major Challenges: Ethical considerations (especially ESCs), immunogenicity, potential tumorigenicity, manufacturing scalability, and cost. MSC sources and applications in regenerative medicine

⭐ Induced Pluripotent Stem Cells (iPSCs) are generated from adult somatic cells by reprogramming with specific transcription factors (e.g., Oct4, Sox2, Klf4, c-Myc - Yamanaka factors), offering patient-specific therapies and bypassing major ethical concerns of ESCs.

Regenerative Medicine - Repair Toolkit

  • Stem Cells: Undifferentiated cells with self-renewal & differentiation potential.

    • Types & Key Features:
      • Totipotent (Zygote): Entire organism.
      • Pluripotent (ESCs, iPSCs): All germ layers. 📌 iPSCs via Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc).
      • Multipotent (MSCs, HSCs): Lineage-restricted (e.g., blood, connective tissue).
      • Unipotent (e.g., skin stem cells): One cell type.
    • Sources: Embryonic, adult (bone marrow, adipose), cord blood, reprogrammed somatic cells (iPSCs).
  • Tissue Engineering Triad: Constructing functional tissues.

    • Cells: Autologous, allogeneic, xenogeneic.
    • Scaffolds: Biocompatible supports (e.g., collagen, PLA, PGA); mimic ECM.
    • Growth Factors: Signaling molecules (FGF, VEGF, BMPs, TGF-β) for cell activity.

image

⭐ iPSCs offer patient-specific pluripotent cells from adult cells, bypassing major ethical/immunological barriers of ESCs.

Regenerative Medicine - Code Breakers

  • Gene Therapy: Introducing, altering, or replacing genetic material to treat/prevent diseases.
    • Delivery Vectors:
      • Viral: Retroviruses, Lentiviruses, Adenoviruses, AAV.
      • Non-viral: Liposomes, nanoparticles, electroporation.
    • CRISPR-Cas9: Powerful gene-editing tool.
      • Mechanism: Guide RNA (gRNA) directs Cas9 endonuclease for DNA cleavage.
      • Applications: Correcting monogenic disorders (Sickle Cell, DMD), cancer therapy.
  • CAR T-cell Therapy: Patient's T-cells engineered with CARs to target cancer.
  • 3D Bioprinting: Additive manufacturing using bio-inks (cells, growth factors) for functional tissues/organs.
  • RNA Therapeutics:
    • mRNA: Vaccines (COVID-19), protein replacement.
    • siRNA/miRNA: Gene silencing.

⭐ CRISPR-Cas9 technology, adapted from a bacterial defense system, allows for highly specific genomic modifications.

CRISPR-Cas9 mechanism: NHEJ and HDR pathways

Regenerative Medicine - Bench to Bedside

  • Core Principles: Repair, replace, or regenerate damaged tissues/organs using cells, tissues, or organs.
    • Bench (Research): Stem cells (embryonic, induced pluripotent, mesenchymal), tissue engineering (scaffolds, growth factors), gene therapy.
    • Bedside (Clinical): Translation of research into patient therapies.
  • Current Clinical Applications:
    • Bone marrow transplantation (hematological disorders).
    • Skin grafts (burns), cartilage repair (osteoarthritis).
    • Corneal regeneration. MSC Sources and Applications in Regenerative Medicine
  • Challenges & Ethical Considerations:
    • Immune rejection, tumorigenicity.
    • Scalability, cost, regulatory hurdles.
    • Ethical sourcing of cells (e.g., ESCs).
  • Indian Scenario:
    • ICMR guidelines for stem cell research.
    • Growing research in academic & private sectors.

⭐ Mesenchymal Stem Cells (MSCs) are a key focus due to their immunomodulatory properties and differentiation potential into osteoblasts, chondrocytes, and adipocytes, with applications in orthopedics and autoimmune diseases.

High‑Yield Points - ⚡ Biggest Takeaways

  • Stem cells are foundational: Embryonic (ESCs), Adult (e.g., HSCs, MSCs), and Induced Pluripotent (iPSCs).
  • iPSCs are reprogrammed adult cells using factors like Oct4, Sox2, Klf4, c-Myc, minimizing ethical issues.
  • Tissue engineering combines cells, biomaterial scaffolds, and growth factors for tissue repair or regeneration.
  • Gene therapy introduces genetic material (e.g., via viral vectors) to treat diseases like SCID.
  • Key applications: HSCT, skin/cartilage repair; promising for cardiac diseases, diabetes, neurodegenerative disorders.
  • Challenges include immunogenicity, tumorigenicity, and significant ethical considerations.

Practice Questions: Regenerative Medicine

Test your understanding with these related questions

Which of the following cell types is classified as a labile cell?

1 of 5

Flashcards: Regenerative Medicine

1/6

Most cases of DVT are _____lateral

TAP TO REVEAL ANSWER

Most cases of DVT are _____lateral

uni

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial